Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Disc Medicine Inc (IRON)

Disc Medicine Inc (IRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,293,034
  • Shares Outstanding, K 38,160
  • Annual Sales, $ 0 K
  • Annual Income, $ -212,180 K
  • EBIT $ -236 M
  • EBITDA $ -244 M
  • 60-Month Beta 0.87
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.18

Options Overview Details

View History
  • Implied Volatility 59.70% (+2.23%)
  • Historical Volatility 63.52%
  • IV Percentile 42%
  • IV Rank 20.78%
  • IV High 131.40% on 01/20/26
  • IV Low 40.89% on 09/12/25
  • Expected Move (DTE 17) 7.78 (12.80%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 2
  • Volume Avg (30-Day) 221
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 3,692
  • Open Int (30-Day) 4,739
  • Expected Range 53.00 to 68.56

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -1.55
  • Number of Estimates 7
  • High Estimate -1.48
  • Low Estimate -1.59
  • Prior Year -1.02
  • Growth Rate Est. (year over year) -51.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
57.72 +5.31%
on 03/19/26
67.16 -9.50%
on 03/02/26
-5.84 (-8.77%)
since 02/27/26
3-Month
40.00 +51.95%
on 02/13/26
83.93 -27.58%
on 02/05/26
-19.55 (-24.34%)
since 12/26/25
52-Week
30.82 +97.21%
on 04/09/25
99.50 -38.91%
on 12/08/25
+8.42 (+16.08%)
since 03/28/25

Most Recent Stories

More News
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

NEW YORK , March 30, 2026 /PRNewswire/ --

IRON : 60.78 (+1.15%)
Investigation Alert: Levi & Korsinsky Investigates Securities Fraud Claims Against Disc Medicine, Inc. (IRON)

New York, New York--(Newsfile Corp. - March 30, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Disc Medicine, Inc. ("Disc Medicine, Inc.") (NASDAQ: IRON) concerning...

IRON : 60.78 (+1.15%)
Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria

Last participant has been randomized and dosed in the Phase 3 APOLLO study of bitopertin in erythropoietic protoporphyria (EPP) The study size was expanded to 183 participants due to patient and physician...

IRON : 60.78 (+1.15%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON

NEW YORK , March 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Disc Medicine, Inc. ("Disc" or the "Company") (NASDAQ: IRON). Such investors are advised...

IRON : 60.78 (+1.15%)
IRON Investors Lose Up to $22/Share -- LEVI & KORSINSKY, LLP Investigates Disc Medicine

Investigation examines gap between reported figures and GAAP results at Disc Medicine ahead of its 21.9% stock collapse

IRON : 60.78 (+1.15%)
Securities Investigation: Levi & Korsinsky Investigates Disc Medicine, Inc. (IRON) on Behalf of Investors

New York, New York--(Newsfile Corp. - March 23, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Disc Medicine, Inc. (NASDAQ: IRON) ("Disc Medicine, Inc.") concerning...

IRON : 60.78 (+1.15%)
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

NEW YORK , March 20, 2026 /PRNewswire/ --

IRON : 60.78 (+1.15%)
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation – IRON

Why: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting...

IRON : 60.78 (+1.15%)
Disc Medicine, Inc. (IRON) Under Investigation for Potential Securities Law Violations - Contact Levi & Korsinsky Today

New York, New York--(Newsfile Corp. - March 18, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Disc Medicine, Inc. ("Disc Medicine, Inc.") (NASDAQ: IRON) concerning...

IRON : 60.78 (+1.15%)
IRON Investors Have Opportunity to Join Disc Medicine, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Disc Medicine, Inc. (“Disc” or “the Company”) (NASDAQ:...

IRON : 60.78 (+1.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Disc Medicine Inc. is a clinical-stage biopharmaceutical company. It focused on the discovery and development of novel treatments for patients suffering from serious hematologic diseases. Disc Medicine Inc., formerly known as Gemini Therapeutics Inc., is based in WAYLAND, Mass.

See More

Key Turning Points

3rd Resistance Point 66.24
2nd Resistance Point 64.17
1st Resistance Point 62.48
Last Price 60.78
1st Support Level 58.72
2nd Support Level 56.65
3rd Support Level 54.96

See More

52-Week High 99.50
Fibonacci 61.8% 73.26
Fibonacci 50% 65.16
Last Price 60.78
Fibonacci 38.2% 57.06
52-Week Low 30.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.